M Steins Selected Research

M Steins Research Topics

6	Neoplasms (Cancer) 01/2014 - 09/2001
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018 - 05/2006
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2006 - 07/2001
3	Lung Neoplasms (Lung Cancer) 08/2011 - 03/2010
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2014 - 01/2010
1	Neoplasm Metastasis (Metastasis) 01/2018
1	Respiratory Tract Diseases (Respiratory Tract Disease) 05/2009
1	Hematologic Neoplasms (Hematological Malignancy) 07/2002
1	Multiple Myeloma 09/2001

3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2010 - 09/2001
2	ErbB Receptors (EGF Receptor)IBA 01/2014 - 01/2010
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2014 - 01/2010
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2014 - 01/2010
1	EnzymesIBA 01/2018
1	NivolumabIBA 01/2018
1	Docetaxel (Taxotere)FDA Link 01/2018
1	Immune Checkpoint InhibitorsIBA 01/2018
1	Monoclonal AntibodiesIBA 06/2010
1	Bevacizumab (Avastin)FDA Link 06/2010
1	PlatinumIBA 06/2010
1	Neuropilin-1IBA 11/2006
1	Semaphorins (Semaphorin)IBA 11/2006
1	Vascular Endothelial Growth FactorsIBA 11/2006
1	Cetuximab (Erbitux)FDA Link 05/2006
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 07/2002
1	Thalidomide (Thalomid)FDA Link 09/2001
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 09/2001
1	Dexamethasone (Maxidex)FDA LinkGeneric 09/2001
1	AngiopoietinsIBA 09/2001
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2001
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 07/2001
1	Semaxinib (SU5416)IBA 07/2001

3	Therapeutics 08/2011 - 03/2010
2	Drug Therapy (Chemotherapy) 06/2010 - 07/2001
1	Palliative Care (Palliative Therapy) 05/2009
1	Radiotherapy 05/2006
1	Induction Chemotherapy 09/2001